Modulation of the hematopoietic stem cell niche by micrometastases
Modulation of the hematopoietic stem cell niche by micrometastases
批准号:
197527381
负责人:
Professor Dr. Martin Bornhäuser
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Units
财政年份:
2011
资助国家:
德国
项目状态:
已结题
起止时间:
2010-12-31 至 2015-12-31
中文摘要
实体肿瘤的微转移,如乳腺癌和前列腺癌,如果遇到造血干细胞生态位的微环境,很容易早期转移到骨髓。肿瘤细胞与骨髓龛成分之间的功能相互作用的分子基础仍然只有部分了解。因此,我们将检验假设一)造血干细胞生态位的细胞成分(间充质基质细胞和造血干细胞,HSC)是否受侵袭的肿瘤细胞影响其遗传特征和功能;以及二)破骨细胞是否调节肿瘤细胞向骨髓生态位的迁移和归巢。初步的自身数据表明,间充质干细胞与肿瘤细胞条件培养液孵育后,趋化因子基质衍生因子-1α(SDF-1)的基因和蛋白水平以时间依赖和可逆的方式降低。成骨信号通路的特异性诱导/抑制,以及肿瘤细胞接触后促炎症细胞因子的分泌,以及破骨细胞在这方面的潜在作用将被研究。该项目的总体目标将是描绘肿瘤细胞侵袭对骨髓微环境动态平衡的影响,并确定潜在的治疗干预目标。
英文摘要
Micrometastases of solid tumors like breast and prostate cancer have a predisposition to metastasize early to the bone marrow were they encounter the microenvironment of the hematopoietic stem cell niche. The molecular basis for the functional interaction between tumor cells with the components of the bone marrow niche remains only partially understood. Therefore, we will test the hypothesis I) whether the cellular components of the hematopoietic stem cell niche (mesenchymal stromal cells, MSC, and hematopoietic stem cells, HSC) are influenced in their genetic profile and function by the invading tumor cells; and II) whether osteoclasts modulate the migration and homing of tumor cells into the bone marrow niche. Preliminary own data suggest that mRNA and protein levels of the chemokine stroma-derived factor-1α (SDF-1) are decreased after MSC incubation with tumor cell-conditioned medium in a time-dependent and reversible manner. The specific induction/repression of osteogenic signaling pathways as well as the secretion of proinflammatory cytokines after tumor cell contact and the potential role of osteoclasts in this context will be investigated. The overall goal of the project will be to delineate the impact of tumor cell invasion on the homeostasis of the bone marrow microenvironment and the identification of potential targets for therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GMP Facility (Good Manufacturing Practice)
-
批准号:214013279
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Professor Dr. Martin Bornhäuser
-
依托单位:
Randomised controlled phase-2 trial to determinate the efficacy of adoptive immunotherapy with haploidentical natural killer cells in high-risk acute myeloid leukemia (HINKL)
-
批准号:201928048
-
项目类别:Clinical Trials
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Professor Dr. Martin Bornhäuser
-
依托单位:
Evaluation of allogeneic cell transplantation in acute myeloid leukemia I (ETAL I)
-
批准号:130027305
-
项目类别:Clinical Trials
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professor Dr. Martin Bornhäuser
-
依托单位:
国内基金
海外基金
骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
-
批准号:82371301
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李轶
-
依托单位:
对12个造血候选基因在小鼠骨髓抑制和再生过程中作用的筛查
-
批准号:30570787
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2005
-
负责人:毛文伟
-
依托单位: